TACR3
MOLECULAR TARGETtachykinin receptor 3
TACR3 (tachykinin receptor 3) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TACR3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | talnetant | 2.77 | 15 |
| 2 | Neurokinin B | 2.64 | 13 |
| 3 | osanetant | 2.48 | 11 |
| 4 | sb 222200 | 2.40 | 10 |
| 5 | Substance P | 2.08 | 7 |
| 6 | Neurokinin | 2.08 | 7 |
| 7 | Eledoisin | 1.95 | 6 |
| 8 | Aprepitant | 0.69 | 1 |
| 9 | Kassinin Dodecapeptide tachykinin found in | 0.69 | 1 |
About TACR3 as a Drug Target
TACR3 (tachykinin receptor 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TACR3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TACR3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.